BioSpace News Archive

Progressive Care Inc., a personalized healthcare services and technology company, is pleased to announce operational performance data for March 2020, which featured breakthrough growth in total sales and a new Company record in total number of prescriptions filled on sharp market share gains

New study will build on recent clinical evidence showing efficacy of DAS181 in improving symptoms of patients with severe COVID-19

CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights a recently published study entitled, “Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis” in the medical journal, The Thoracic and Cardiovascular Surgeon.

Note: All times local Ottawa, Ontario The Deputy Prime Minister will chair the Cabinet Committee on the federal response to the coronavirus disease (COVID-19). Closed to media. 12:00 p.m. The Deputy Prime Minister will join ministers and Government of Canada officials

Three new honorary doctors have been appointed by The Board of Research at Karolinska Institutet . Pascale Cossart , Sven Hagströmer, and Thomas Sakmar will have their doctorates formally conferred at Stockholm City Hall on 13 November 2020 . An honorary doctorate can be awarded to researchers who have contributed to science,

Moleculin Biotech, Inc., today announced that Dr. Dominique Schols of the Rega Institute has joined the development team as a consultant

Swedish Heart-Lung Home Monitor Expands Indications for use in COVID-19 Respiratory Diagnostic Exams

Histogen Inc. announced the publication of data on its human extracellular matrix for cartilage regeneration in the Journal of Orthopaedic and Trauma Care.

Investor call today at 4:30 pm ET to discuss operational update and cost-saving measures being implemented

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, fulfills its ongoing commitment to improve the continuum of cancer care by implementing the Lymphedema Prevention Program and installing four SOZO® devices in its Duarte, California, facility.